Evidence map›Paper›PMID 9275207›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1997

Expression of adenoviral E3 transgenes in beta cells prevents autoimmune diabetes.

M G von Herrath, S Efrat, M B Oldstone, M S Horwitz

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Adenovirus E3 MHC inhibitory genes but not TNF/Fas apoptotic inhibitory genes expressed in beta cells prevent autoimmune diabetes.Proceedings of the National Academy of Sciences of the United States of America · 2009
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Molecular mimicry and immune-mediated diseases.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 1998
    Review
  18. The adenovirus E3/10.4K-14.5K proteins down-modulate the apoptosis receptor Fas/Apo-1 by inducing its internalization.Proceedings of the National Academy of Sciences of the United States of America · 1998
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

M G von HerrathDivision of Virology, Department of Neuropharmacology, The Scripps Research Institute, La Jolla, CA 92037, USA.
S Efrat
M B Oldstone
M S Horwitz
Scripps Research Institute · USColumbia University Irving Medical Center · US

Funding

VIROLOGY AND IMMUNOLOGY OF AGINGP01AG004342 · NIA · SCRIPPS RESEARCH INSTITUTE, THE · PI OLDSTONE, MICHAEL B · 1985 to 2008
$12.9M
DNA Vaccination &Regulatory Cells in Type I DiabetesR01DK051091 · NIDDK · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI VON HERRATH, MATTHIAS G. · 2003 to 2006
$1.1M
PATHOGENESIS AND TREATMENT OF AUTOIMMUNE DIABETESR29DK051091 · NIDDK · SCRIPPS RESEARCH INSTITUTE · PI VON HERRATH, MATTHIAS G. · 1996 to 2001
$180k
NIA NIH HHS AG 04342NIA NIH HHS P01 AG004342NIDDK NIH HHS DK51091NIDDK NIH HHS R01 DK051091NIDDK NIH HHS R29 DK051091
6 · The paper itself

Abstract

The adenovirus (Ad) genome contains immunoregulatory and cytokine inhibitory genes that are presumed to function in facilitating acute infection or in establishing persistence in vivo. Some of these genes are clustered in early region 3 (E3), which contains a 19-kDa glycoprotein (gp19) that inhibits the transport of selected class I major histocompatibility complex (MHC) molecules out of the endoplasmic reticulum. In addition, the E3 region contains three protein inhibitors of the cytolytic function of tumor necrosis factor alpha (TNF-alpha). Because type I autoimmune diabetes destroys islets by mechanisms that involve class I MHC and TNF-alpha, we investigated whether the entire cassette of Ad E3 genes might prevent the onset of diabetes in a well studied lymphocytic choriomeningitis viral (LCMV) murine model of virus-induced autoimmune diabetes. In this model, a LCMV polypeptide (either glycoprotein or nucleoprotein) expressed as a transgene in the islets is a target for autoimmune destruction of beta cells after LCMV infection. In this scenario the LCMV-induced immune response is directed not only against the virus but also against the LCMV transgenes expressed in the beta cells. Our experiments demonstrated a very efficient prevention of this LCMV-triggered diabetes by the Ad E3 genes. This resulted from the inhibition of target cell recognition by a fully competent and LCMV-primed immune system. Unlike the results from the beta-2 microglobulin gene deletion experiments, our approach shows that selective regulation at the level of the target cell is sufficient to prevent autoimmune diabetes without disrupting the function of the systemic immune response. Although the Ad genes in these experiments were provided as transgenes, recent experiments may permit the introduction of such genes through the use of viral vectors. Although the decrease in class I MHC in islets by Ad genes was demonstrated in these in vivo studies, the relative importance of this process and the control of TNF-alpha cytolysis must await further genetic dissection of the introduced Ad genes.

Indexed as

AdenoviridaeAdenovirus E3 ProteinsAnimalsDiabetes Mellitus, Type 1Gene ExpressionGene Expression RegulationGene Transfer TechniquesMajor Histocompatibility ComplexMiceMice, TransgenicAdenovirus E3 Proteins

Identifiers

PMID9275207
PMCPMC23273
OpenAlexW2123813842

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.